Financial recovery of B&N Bank to last 6-8 months — Central BankBusiness & Economy September 21, 14:33
Russian senator says Morgan Freeman used instead of evidence in anti-Russian videoRussian Politics & Diplomacy September 21, 14:17
Moldova’s liberals initiate presidential impeachmentWorld September 21, 14:06
Fan-ID system helped against racism during FIFA Confederations Cup — officialSport September 21, 13:35
Russian warship sails through English ChannelMilitary & Defense September 21, 13:12
Kremlin slams attempts to brand Russia as aggressor while discussing UN mission to DonbassRussian Politics & Diplomacy September 21, 13:07
Press review: Peacekeepers in Ukraine stalled and Russia suspects US leak to IslamistsPress Review September 21, 13:00
Kremlin shares Defense Ministry's stance on US role in militants’ attack in SyriaRussian Politics & Diplomacy September 21, 12:36
Admiral Essen frigate returns to Sevastopol from Mediterranean SeaMilitary & Defense September 21, 12:03
KALUGA, June 5. /TASS/. A new pharmaceutical plant, Nearmedic Pharma, located on the territory of a major innovation and industrial Kaluga region, in central Russia, is starting manufacturing medicines.
The project worth $73 million is implemented in cooperation with the national holding company Nearmedic and the Russian Corporation of Nanotechnologies, the press service of Nearmedic Plus told TASS.
The new plant complies with international standards GMP, ISO and FDA. The total annual output reaches up to 100 million medical products, including anti-viral medications.
"The plant is unique as the whole cycle from the synthesis of incoming substances to manufacturing of finished pharma products comes in the framework of one production unit and the product range is the company’s innovations," the press service said.
All the pharmaceutical companies in Russia's Kaluga region are united in a single pharma cluster which now consists of 54 companies.